- Home
- MKZR vs BFRI Comparison
MKZR vs BFRI Comparison
Compare MKZR & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- BFRI
- Stock Information
- Founded
- MKZR 2012
- BFRI 1997
- Country
- MKZR United States
- BFRI United States
- Employees
- MKZR N/A
- BFRI N/A
- Industry
- MKZR
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- MKZR
- BFRI Health Care
- Exchange
- MKZR Nasdaq
- BFRI Nasdaq
- Market Cap
- MKZR 10.3M
- BFRI 11.1M
- IPO Year
- MKZR N/A
- BFRI 2021
- Fundamental
- Price
- MKZR $4.20
- BFRI $0.79
- Analyst Decision
- MKZR
- BFRI Strong Buy
- Analyst Count
- MKZR 0
- BFRI 1
- Target Price
- MKZR N/A
- BFRI $2.75
- AVG Volume (30 Days)
- MKZR 32.1K
- BFRI 193.0K
- Earning Date
- MKZR 11-14-2025
- BFRI 11-12-2025
- Dividend Yield
- MKZR 24.69%
- BFRI N/A
- EPS Growth
- MKZR N/A
- BFRI N/A
- EPS
- MKZR N/A
- BFRI N/A
- Revenue
- MKZR $20,994,778.00
- BFRI $37,164,000.00
- Revenue This Year
- MKZR N/A
- BFRI $9.70
- Revenue Next Year
- MKZR N/A
- BFRI $12.58
- P/E Ratio
- MKZR N/A
- BFRI N/A
- Revenue Growth
- MKZR 3.63
- BFRI 5.11
- 52 Week Low
- MKZR $3.86
- BFRI $0.54
- 52 Week High
- MKZR $50.00
- BFRI $1.87
- Technical
- Relative Strength Index (RSI)
- MKZR 38.42
- BFRI 40.21
- Support Level
- MKZR $3.92
- BFRI $0.71
- Resistance Level
- MKZR $4.86
- BFRI $0.83
- Average True Range (ATR)
- MKZR 0.41
- BFRI 0.09
- MACD
- MKZR -0.05
- BFRI -0.01
- Stochastic Oscillator
- MKZR 20.88
- BFRI 25.15
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.